Skip to main content
. Author manuscript; available in PMC: 2019 Jul 15.
Published in final edited form as: Clin Cancer Res. 2018 Apr 4;24(14):3299–3308. doi: 10.1158/1078-0432.CCR-17-3008

Figure 3. Comparing the overall or disease-free survival between patients with (red) and without (blue) HDIs/HDDs.

Figure 3

(A) Overall survival curves for brain lower grade glioma (LGG). (B) Overall survival curves for glioblastoma multiforme (GBM). (C) Disease-free survival curves for prostate adenocarcinoma (PRAD). (D) Disease-free survival curves for colorectal cancer. Colorectal cancer is the combined cohort of colon adenocarcinoma (COAD) and rectum adenocarcinoma (READ). (E) Disease-free survival curves for bladder urothelial carcinoma (BLCA). (F) Overall survival curves for lung cancers. Lung cancer is the combined cohort of lung adenocarcinoma (LUAD) and lung quamous cell carcinoma (LUSC).